These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28945187)

  • 1. VPA does not enhance platinum binding to DNA in cisplatin-resistant neuroblastoma cancer cells.
    Raudenska M; Krejcova L; Richtera L; Heger Z; Hrabeta J; Eckschlager T; Stiborova M; Adam V; Kratochvilova M; Masarik M; Gumulec J
    Tumour Biol; 2017 Sep; 39(9):1010428317711656. PubMed ID: 28945187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium.
    Blaheta RA; Michaelis M; Natsheh I; Hasenberg C; Weich E; Relja B; Jonas D; Doerr HW; Cinatl J
    Br J Cancer; 2007 Jun; 96(11):1699-706. PubMed ID: 17505515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells.
    Groh T; Hrabeta J; Khalil MA; Doktorova H; Eckschlager T; Stiborova M
    Int J Oncol; 2015 Jul; 47(1):343-52. PubMed ID: 25963435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
    Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.
    Arzuman L; Beale P; Yu JQ; Proschogo N; Huq F
    Anticancer Res; 2014 Dec; 34(12):7077-90. PubMed ID: 25503135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs.
    Jansen BA; Brouwer J; Reedijk J
    J Inorg Biochem; 2002 Apr; 89(3-4):197-202. PubMed ID: 12062123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization.
    Bedrnicek J; Vicha A; Jarosova M; Holzerova M; Cinatl J; Michaelis M; Cinatl J; Eckschlager T
    Neoplasma; 2005; 52(5):415-9. PubMed ID: 16151587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid overcomes hypoxia-induced resistance to apoptosis.
    Cipro Š; Hřebačková J; Hraběta J; Poljaková J; Eckschlager T
    Oncol Rep; 2012 Apr; 27(4):1219-26. PubMed ID: 22159638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells.
    Cerna T; Hrabeta J; Eckschlager T; Frei E; Schmeiser HH; Arlt VM; Stiborová M
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29304031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N; Lam YM; Pym J; Campling BG
    Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells.
    Cetraz M; Sen V; Schoch S; Streule K; Golubev V; Hartwig A; Köberle B
    Arch Toxicol; 2017 Feb; 91(2):785-797. PubMed ID: 27307157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-phenylethyl isothiocyanate reverses platinum resistance by a GSH-dependent mechanism in cancer cells with epithelial-mesenchymal transition phenotype.
    Wu WJ; Zhang Y; Zeng ZL; Li XB; Hu KS; Luo HY; Yang J; Huang P; Xu RH
    Biochem Pharmacol; 2013 Feb; 85(4):486-96. PubMed ID: 23219523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression.
    Blaheta RA; Daher FH; Michaelis M; Hasenberg C; Weich EM; Jonas D; Kotchetkov R; Doerr HW; Cinatl J
    BMC Cancer; 2006 Dec; 6():294. PubMed ID: 17181871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dinuclear berenil-platinum(II) complexes on fibroblasts redox status.
    Gęgotek A; Markowska A; Łuczaj W; Bielawska A; Bielawski K; Ambrożewicz E; Skrzydlewska E
    Adv Med Sci; 2013; 58(2):282-91. PubMed ID: 24127544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
    Kelland LR; Sharp SY; O'Neill CF; Raynaud FI; Beale PJ; Judson IR
    J Inorg Biochem; 1999 Oct; 77(1-2):111-5. PubMed ID: 10626362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C; Mulder NH; Timmer-Bosscha H; Sluiter WJ; Meersma GJ; de Vries EG
    Cancer Res; 1992 Dec; 52(24):6885-9. PubMed ID: 1458477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic Signature of Neuroblastoma Cells UKF-NB-4 Reveals Key Role of Lysosomal Sequestration and the Proteasome Complex in Acquiring Chemoresistance to Cisplatin.
    Merlos Rodrigo MA; Buchtelova H; de Los Rios V; Casal JI; Eckschlager T; Hrabeta J; Belhajova M; Heger Z; Adam V
    J Proteome Res; 2019 Mar; 18(3):1255-1263. PubMed ID: 30592607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identifying the Importance of MT-3 Expression for Neuroblastoma Cells].
    Eckschlager T; Vícha A; Jenčová P; Merlos R; Dostálová S; Buchtelová H; Strmiska V; Michálek P; Heger Z; Adam V
    Klin Onkol; 2018; 31(Supplementum1):145-147. PubMed ID: 29808689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.
    Poljakova J; Hrebackova J; Dvorakova M; Moserova M; Eckschlager T; Hrabeta J; Göttlicherova M; Kopejtkova B; Frei E; Kizek R; Stiborova M
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():101-16. PubMed ID: 22167207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.